Resources
Reports, Whitepapers & Articles
Report
The Front-End Shift: How Pharma Is Reallocating Patient Services Spend
Our March Patient Services Report explores a fundamental shift in life sciences: the reallocation of patient services spend toward purpose-built, front-end patient and HCP engagement. As manufacturers face delayed starts and early discontinuation, leading organizations are prioritizing engagement models that address the human and behavioral drivers of access, affordability, and adherence—before patients fall through the cracks. The front-end shift is here.
Report
The Heart of Connection: Quantitative Impact of CNE Engagement Strategies
Nurse-led engagement continues to play an important role in shaping the patient experience, particularly at therapy initiation. Our February Patient Services Report examines how Clinical Nurse Educator engagement strategies correlate with trends in patient opt-in, first-fill, and longer-term persistency. Explore how early, education-based support may influence engagement across the therapy journey.
Report
Creating Momentum in Patients’ Lives
Behind every prescription is a moment that can determine what happens next. An access denial that nearly halted therapy. A caregiver unsure how to manage a new diagnosis. A patient hesitant to begin treatment without clarity. This report shares real stories of how nurse-led coordination, education, and follow-through helped patients and families move forward with confidence. Across therapeutic areas, these experiences reflect the measurable difference thoughtful, clinically grounded support can make.
Report
Transforming Patient Experience: Key Trends Shaping Engagement in 2026
Patient expectations are evolving, and engagement models are adapting in response. Our Patient Services Report examines the trends shaping patient engagement today, from hybrid support models and governed AI to the role of behavioral science in patient education. Explore how these shifts are influencing patient experience and adherence across the journey.
Presentations & Webinars
Webinar
Beyond the Numbers: Demonstrating Hub Model Value in Specialty and Rare Disease Patient Support
Join Josh Konetzni and Melissa Beatty to explore evaluating hub models for adherence, outcomes, and demonstrating patient support value in complex therapies.
Webinar
Adherence Challenges in Rare and Specialty
Up to 65% of rare disease patients stop medication, half within a year. This segment of our latest webinar reveals adherence challenges and how personalized support boosts persistency by 61%, maximizing therapy value.
Webinar
Hub Model Evolution and Types
Explore the evolution of pharma hub models, from basic access to complex patient engagement. Rising drug costs and patient needs drive today's hybrid models, combining insourced control with outsourced expertise for flexible, data-driven, personalized care.
Webinar
Adapting to Shifting Market Dynamics
Pharma's changing: patent expirations and new therapies reshape patient support. Flexible hybrid hubs are essential for agility, investment, and engagement. Future-proof your strategy.
Blog
From Logistics to Relationship: Reimagining Patient Engagement Through Empathy and Connection
Redefining the Patient Journey in the Age of DTC
A quiet revolution is reshaping how therapies reach patients — and it’s happening faster than anyone expected. The pharmaceutical industry is experiencing a transformative shift towards Direct-to-Consumer (DTC) models, driven by several legislative and regulatory changes.
Where Human Expertise Meets AI: Advancing Patient Engagement
Artificial intelligence (AI) has advanced rapidly in its ability to understand language and detect emotion, giving pharmaceutical manufacturers powerful tools to scale and customize patient engagement. But AI on its own can’t deliver the kind of empathetic support patients truly need.
Three Pillars of Rare Disease Support: Building an Essential Network
Discover the three essential pillars of rare disease support: medical expertise, community connections, and family engagement. Learn how integrating these elements creates comprehensive support networks for the 1 in 1,500 Americans affected by rare diseases.
Case Studies
OneVoice + RightStart ALS
The client leveraged the RightStart™ platform to deliver education and training to nurses and office staff.
RightStart Car-T
Community Hematology Oncologists lack CAR-T awareness, knowledge and comfort that Clinical Nurse Educators can address.
OneVoice Case Study – Rare Disease
Company received product approval in 2017, and by 2020 had expansive financial support in place, including a 3rd party HUB and Copay program.
OneVoice + RightStart Neuroscience
Company received product approval in 2020, and by mid-2021 had an expansive patient support program in place.
Press Releases
Momentum Life Sciences Named One of America’s Top 100 Most Loved Workplaces® for 2025 — Ranking #30
Indianapolis, IN - October 21, 2025 - Momentum Life Sciences, a leader in patient engagement solutions, has been named one of the 2025 America’s Top 100 Most Loved Workplaces®, ranking #30 among companies nationwide.
Momentum Celebrates Winners of Premier Patient Support Awards: The GoMentum Awards 2025
INDIANAPOLIS, IN – [October 8, 2025] – Momentum Life Sciences announces the winners of the premier Patient Support Awards, also known as the GoMentum Awards 2025. This inaugural program recognizes outstanding patient support initiatives that go above and beyond to create greater momentum for patients and providers across the life sciences industry.
Momentum Life Sciences Earns Dual Recognition as 2025 PM360 Trailblazer Awards Finalist
PM360 Magazine Names Jennifer Wagner of Momentum Life Sciences to 2025 Elite 100 for Transformational Leadership
Indianapolis, Indiana – May 13, 2025 - Momentum Life Sciences proudly announces that Jennifer Wagner, Vice President of Client Solutions, has been selected for the prestigious 2025 Elite 100 by PM360 Magazine in the Transformational Leadership category for her exceptional impact on healthcare innovation and delivery.